Ursula R. Kees
Perth, WA, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 37 publications
Targeting osteoclasts for treatment of high-risk B-cell acute lymphoblastic leukemia.
Journal: Blood cancer journal
Published: March 29, 2024
Preclinical efficacy of azacitidine and venetoclax for infant KMT2A-rearranged acute lymphoblastic leukemia reveals a new therapeutic strategy.
Journal: Leukemia
Published: April 30, 2022
Preclinical Evaluation of Carfilzomib for Infant KMT2A-Rearranged Acute Lymphoblastic Leukemia.
Journal: Frontiers in oncology
Published: November 20, 2020
Incidence of NUT carcinoma in Western Australia from 1989 to 2014: a review of pediatric and adolescent cases from Perth Children's Hospital.
Journal: BMC cancer
Published: September 06, 2020
The bone marrow microenvironment of pre-B acute lymphoblastic leukemia at single-cell resolution.
Journal: Scientific reports
Published: July 29, 2020
Exploiting the reactive oxygen species imbalance in high-risk paediatric acute lymphoblastic leukaemia through auranofin.
Journal: British journal of cancer
Published: January 29, 2020
Identifying the optimal donor for natural killer cell adoptive therapy to treat paediatric B- and T-cell acute lymphoblastic leukaemia.
Journal: Clinical & translational immunology
Published: January 07, 2020
Potent antileukemic activity of curaxin CBL0137 against MLL-rearranged leukemia.
Journal: International journal of cancer
Published: February 27, 2019
Romidepsin enhances the efficacy of cytarabine in vivo, revealing histone deacetylase inhibition as a promising therapeutic strategy for KMT2A-rearranged infant acute lymphoblastic leukemia.
Journal: Haematologica
Published: January 26, 2019
New therapeutic opportunities from dissecting the pre-B leukemia bone marrow microenvironment.
Journal: Leukemia
Published: January 14, 2018
Last Updated: 09/26/2026